Login:
 
Lack of legacy effect from tight glycaemic control in type 2 diabetes. Practitioner July/August 2019;263(1828):7

Lack of legacy effect from tight glycaemic control in type 2 diabetes

07 Aug 2019Pais-up subscribers

Adults with type 2 diabetes who had received intensive glucose lowering therapy for nearly six years had a lower risk of cardiovascular events than those who received standard therapy only during the prolonged period in which the HbA1C curves were separated, a study from the US has found. There was no evidence of a legacy effect or a mortality benefit with intensive glucose control 15 years after commencement of the study.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .